Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication

International Angiology

Volumn 20, Issue 4, 2001, Pages 337-344

  Diamantopoulos, E J ^a   Grigoriadou, M ^a   Ifanti, G ^a   Raptis, S A ^a  

^a 4th Department of Internal Medicine   (Greece)

Author keywords

Blood platelets; Diabetic angiopathies; Intermittent claudication, drug therapy; Pyrrolidines, therapeutic use; Vasodilator agents

Indexed keywords

ADENOSINE DIPHOSPHATE; BETA THROMBOGLOBULIN; BUFLOMEDIL; COLLAGEN; GLIBENCLAMIDE; INSULIN; PHENFORMIN; PLACEBO; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; BLOOD FILTRATION; BLOOD RHEOLOGY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; ERYTHROCYTE DEFORMABILITY; FEMALE; HUMAN; INTERMITTENT CLAUDICATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTE AGGREGATION; TREADMILL EXERCISE; WALKING;

DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMORHEOLOGY; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; PLATELET AGGREGATION; PYRROLIDINES; VASODILATOR AGENTS;

EID: 0035575249     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Thrombozytenaktivität und Erythozytenrigidität bei Altersdiabetikern mit arterieller Verschlusskrankheit der unteren Extremitäten
2. Rheology and occlusive arterial disease of the legs
3. Abnormal rheologic effects of glyceryl trinitrate in patients with non-insulin-dependent diabetes mellitus and reversal by antioxidants
4. The fibrinolytic system in diabetes mellitus
5. Reversible haematological sequelae of diabetes mellitus
6. Capillary basement membranes in diabetes
7. Relationship between hemorheological and microcirculatory abnormalities in diabetes mellitus
8. Impaired red blood cell deformability in diabetic angiopathy
9. Red blood cell deformability index in diabetic retinopathy
10. Modification of hemorheological parameters in microvascular complications of diabetes
11. Increased binding of fibrinogen to platelets in diabetics; The role of prostaglandins and thromboxane
12. Diabetes mellitus as a hypercoagulable state; Its relationship with fibrin fragments and vascular damage
13. Increased platelet aggregation in early diabetes mellitus
14. Increased platelet activity in diabetic macroangiopathy
15. Prognostic significance of rheological and biochemical findings in patients with intermittent claudication
16. A meta-analysis of randomized, double-blind, placebo-controlled studies of the effect of buflomedil on intermittent claudication
17. Whole blood filterability in chronic cerebrovascular disorders: Effects of the use of buflomedil hydrochloride
18. In vitro studies of the effect of buflomedil on platelet responsiveness
19. A simple method for measuring erythrocyte deformability
20. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review
21. Conservative management of intermittent claudication
22. Trans-Atlantic Conference on clinical trial guidelines in PAOD clinical trial methodology
23. Clinical trials for claudication. Assessment of exercise performance, functional status and clinical endpoints
24. Treadmill testing for evaluation of claudication: Comparison of constant-load and graded-exercise tests
25. Assessment of collateral perfusion: A pharmacodynamic study with buflomedil hydrochloride
26. Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo
27. Effects of buflomedil on erythrocyte deformability
28. Effects of buflomedil on microvascular disorders in diabetic patients